So, if that is the case--either one of you can answer--what would be the incentive for the drug companies who are getting reimbursed by insurance for these $1,000 pills to be innovative and come up with less costly, effective drugs?
Questioning the incentive for drug companies to innovate given high reimbursement rates.
Share
More from Mazie Hirono
In functionally overturning the last enforceable section of the Voting Rights Act, the Supreme Court has once again put the interests of Republicans and their billionaire buddies before the voting rights of millions of Americans.
Notwithstanding rule XXII, I ask unanimous consent that the Senate proceed to the immediate consideration of the following bills, en bloc: Calendar No. 617, H.R. 6062, and Calendar No. 393, S. 2615. There being no objection, the Senate…
I have to say that I sit on five committees in the Senate, and the Veterans Committee is one that really is characterized by bipartisanship.
As far as I'm concerned, we did not do that adequately during the Kavanaugh hearings.
Other voices in this conversation
